**IDEX Corporation (IEX)** reported strong business performance with a market capitalization of **$16.4 billion** and a Zacks Rank of **#2 (Buy)**. In the second quarter of **2026**, the Health & Science Technologies (HST) segment saw an organic sales increase of **12%**, with organic orders rising **47%**, enhancing backlog visibility into **2027**. The Fluid & Metering Technologies (FMT) segment recorded a **1%** increase in organic sales and an **11%** increase in orders.
The company also raised its **2026** organic sales growth forecast from **3-4%** to **5-6%** due to stronger HST order backlogs. IDEX’s recent acquisition of Micro-LAM contributed **1%** to consolidated sales growth in Q2, enhancing its capabilities in the materials science domain. In the first half of **2026**, IDEX returned **$106.7 million** to shareholders in dividends and **$153.4 million** in share buybacks, maintaining a share repurchase authorization balance of **$774.7 million**.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
